CD34 and neoplasm: Tumor cells were negative with the wide-spectrum cytokeratin panel (HMW-CK, LMW-CK, CK8/18, CK7, CK20), and also negative for CD34, Myogenin, S100, CD117 (KIT), CD31, ALK1, and CD99.